
Rowan SOM '23 l George Washington University '17 A proud product of Lawrenceville, NJ Passionate about #Neurosciences #ClinicalResearch ~Vibes and Haldi~
Joined February 2010
- Tweets1.1K
- Following1K
- Followers698
- Likes19K
Shelly Sharma retweeted
自己免疫性脳炎のMRI所見を抗体別に整理した総説
側頭葉内側のFLAIR高信号が典型的だが皮質/基底核/脳幹にも病変を生じMRI正常例もある
病変分布と臨床症状、髄液/抗体検査を組合わせ感染症などとの鑑別と早期診断を行う重要性を解説
OA
#encephalitis
#immunology
#papers
pubs.rsna.org/doi/10.1148/ra…
Shelly Sharma retweeted
The country saw nyc living its best Mamdani life & said we'll have what they're having
On this #WorldStrokeDay, GW Neurology reaffirms its commitment to helping not only provide excellent stroke care, but educate folks about signs and symptoms of #Strokes
It’s all about BE FAST 🕰️ 🏃🏾♀️
#StrokeAwareness
@AANmember
Shelly Sharma retweeted
hi everyone, it's finally finished. here is our NYC food recs masterlist of 2026 (& love letter to the city). hope anyone coming here for worlds (or otherwise) has an incredible time 💕🥂 docs.google.com/document/d/1…
Do you enjoy nerding out over 🧠, love a city with a vast food scene, & coresidents who want to make work fun?
Then GW Neurology may be the right program for you! Join us on Sept 15 @ 7 pm EST for our virtual open house
@NMatch2027 @AANmember @NowyouknowNeuro
Shelly Sharma retweeted
One of my missions is to make Peripheral Neuropathies more understandable for non-experts. Recognizing that physicians often find PNs challenging, especially in the hospital setting, I collaborated with @MayoClinicNeuro Neuromuscular hospitalists, @ReeceHass and @SantilliAshley, and my former NM co-fellow #JMartinezThompson to develop an engaging infographic that simplifies how to approach neuropathies leading to hospitalization. The incredible artistic skills and creativity of @ReeceHass truly brought this project to life, exceeding all expectations. We hope you find this helpful. neurology.org/doi/pdf/10.121…
Shelly Sharma retweeted
We are very proud to release our acute #Stroke imaging course. This free online real world case-based learning environment is meant for students of all levels. From beginners to experienced MD’s, we can all benefit to take better care of our patients!
uthealth.catalog.instructure…
Shelly Sharma retweeted
A new #frontier in #endovascular #neurosurgery.
Proud to share our latest publication on @JNIS_BMJ on the endovascular treatment of intracranial #meningiomas—the largest multicenter retrospective series reported to date.
This is only the beginning. The future belongs to those who build it.
For more opportunities: unilink.it/en/master/academi…
#Neurosurgery #Endovascular #Meningioma #Research
Brought a bit of @AANmember to Machu Picchu! 🇵🇪
Thanks for the sun protection 🧢 🧠
#BestiesTrip2023 in Curaçao 🇨🇼
Nothing beats having a best friend who will always travel the world with you- even if it includes rough boat rides, go on adventures just to find Arepas, & make sure that you constantly reapply sunscreen
#BestiesTrip2024 in Costa Rica 🇨🇷 Truly living our Pura Vida with adorable sloths, good food/ drinks, & most of all incredible memories
#BestiesTrip2026 in Peru 🇵🇪 4 flights, 2 trains, roughly 6 bus rides, & many alpacas, llamas later we finally checked this off our travel list
Had an amazing time at #AANAM- learning, connecting with friends from medical school, talking to current students, such cool research, but the best part the puppies! 🧠
Shelly Sharma retweeted
🚨 #ISC26 delivered BIG for stroke care. Multiple practice-important and promising trials across thrombosis, reperfusion, EVT, ICH, and neuroprotection 🏥🧠👇
🔹 OCEANIC-STROKE – Positive phase III: FXIa inhibition with asundexian reduced ischemic stroke in patients with non-cardioembolic stroke or high-risk TIA on antiplatelet therapy without increased major bleeding
🔹 OPTION – In patients with salvageable tissue, tenecteplase (4.5–24h) significantly improved 90-day excellent outcomes with higher sICH (2.8% vs 0%)
🔹 CHOICE-2 – Largest phase III trial of IA alteplase after successful EVT: higher excellent outcomes (mRS 0–1), no increase in sICH, NNT ≈ 7
🔹 FASTEST – rFVIIa for spontaneous ICH: promising early results in spot sign–positive patients treated <90 min
🔹 LAIS – Loberamisal (dual-target neuroprotection) within 48h for AIS (NIHSS 7–20): 13% absolute increase in excellent functional outcomes at 90 days
🔹 DISTALS – Tigertriever for distal occlusions: higher successful reperfusion at 24h without increased sICH
🔹 ORIENTA-MeVO – EVT for MeVO improved 90-day functional outcomes without excess sICH in a Chinese population
The stroke playbook is evolving in real time. 🔥
#Stroke #ISC26 #VascularNeurology #EVT #Tenecteplase #ICH #ClinicalTrials #AHAScience #StrokeResearch @StrokeAHA_ASA @AHAScience 🧠
Shelly Sharma retweeted
Here is an app that I’ve created for cognitive testing. It’s freely available and collates most of the commonly used bedside tests in Neurology/Neurosurgery. Let me know if anyone has any suggestions, recommendations or questions!
mindmap-lobes-app.lovable.ap…
Shelly Sharma retweeted
Watch. To. The. End.
#SVIN2025 just casually dropped a bombshell:
CREST-2 says carotid stenting > CEA + medical management.
Yes, you read that right.
The data has spoken: ARD 3.2%, RR 2.13, and the p-value didn’t come to play.
The plenary hall was purely electric.
You could feel the field shift in real time. – at Doctor Phillips, FL
YES MIKIE SHERRILL & NEW JERSEY!!!! So proud of my fave state for recognizing strong leadership and someone who will stand up for ALL people #Election2025
Spreading the gospel of ~ time is brain~ not only during the last week of nights but at
@cyclebar
! Glad I made all my post night float AM rides & survived residency night float 🙌🏽
#neurology 🧠




































